Evidence map›Paper›PMID 40254620›Full record

ArticleScientific reports2025

VIRMA promotes NSCLC progression by modifying ADAR m

Yuchen Shan, Yongfei Fan, Xudong Zhu, Yi Zhao, Xiangseng Liu, Xiaoyu Duan, Zhaojia Gao, Ming Lou, Kai Yuan

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. mFrontiers in cell and developmental biology · 2026
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yuchen ShanDepartment of Thoracic Surgery, The Second People's Hospital of Changzhou (the Third Affiliated Hospital of Nanjing Medical University), Changzhou, 213003, China.
Yongfei FanDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200092, China.
Xudong ZhuDepartment of Thoracic Surgery, The Second People's Hospital of Changzhou (the Third Affiliated Hospital of Nanjing Medical University), Changzhou, 213003, China.
Yi ZhaoDepartment of Thoracic Surgery, The Second People's Hospital of Changzhou (the Third Affiliated Hospital of Nanjing Medical University), Changzhou, 213003, China.
Xiangseng LiuDepartment of Thoracic Surgery, The Second People's Hospital of Changzhou (the Third Affiliated Hospital of Nanjing Medical University), Changzhou, 213003, China.
Xiaoyu DuanDepartment of Thoracic Surgery, The Second People's Hospital of Changzhou (the Third Affiliated Hospital of Nanjing Medical University), Changzhou, 213003, China.
Zhaojia GaoDepartment of Thoracic Surgery, The Second People's Hospital of Changzhou (the Third Affiliated Hospital of Nanjing Medical University), Changzhou, 213003, China.
Ming LouDepartment of Thoracic Surgery, The Second People's Hospital of Changzhou (the Third Affiliated Hospital of Nanjing Medical University), Changzhou, 213003, China.
Kai YuanDepartment of Thoracic Surgery, The Second People's Hospital of Changzhou (the Third Affiliated Hospital of Nanjing Medical University), Changzhou, 213003, China. yuankai1978@163.com.

Funding

333 High-Level Talent Training Project 2022-2"333 Project" of Jiangsu Province BRA2020157Changzhou High-Level Medical Talents Training Project 2022CZBJ069Changzhou Sci&Tech Program CZ20220025Changzhou University - Changzhou Second People's Hospital Nursing Specialized Research Project CDHL202203Clinical Research Project of Changzhou Medical Center of Nanjing Medical University CMCB202205High-level Talent Selection and Training Project of the 16th Batch of "Six Talent Peak" in Jiangsu Province WSN-245Medical Scientific Research Foundation of Jiangsu Commission of Health H2018083"Six One Project," Research Projects of High-level Medical Personnel of Jiangsu Province LGY2019025
6 · The paper itself

Abstract

The N

Indexed as

AdenosineAdenosine DeaminaseCarcinoma, Non-Small-Cell LungLung NeoplasmsRNA-Binding ProteinsSignal TransductionTransforming Growth Factor betaA549 CellsAnimalsApoptosisCell Line, TumorCell MovementCell ProliferationDisease ProgressionFemaleGene Expression Regulation, NeoplasticADAR protein, humanAdenosineAdenosine DeaminaseN-methyladenosineRNA-Binding ProteinsTransforming Growth Factor betaADARm6A RNA methylationNon-Small cell lung cancerTGF-β signaling pathwayVIRMA

Identifiers

PMID40254620
PMCPMC12010004

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.